PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling

doi:10.4251/wjgo.121827

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 10

This Article

(5)

(4)

(0)

(1)

(10)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121827
Published online Oct 15, 2026. doi: 10.4251/wjgo.121827

Full Size Figure Download Figure

Figure 1 Public database and single-cell transcriptomic analyses of PARVA in gastric cancer. A: Pan-cancer differential expression analysis in Sangerbox 3.0; B: Overall distribution of PARVA expression in normal and tumor tissues; C: PARVA expression in gastric cancer and normal gastric tissues in GEPIA; D: Representative immunohistochemical staining of PARVA in gastric cancer tissues from THPA; E: Survival analysis of PARVA in gastric cancer from THPA; F: Single-cell transcriptomic analysis of the STAD_GSE134520 dataset from TISCH, showing cell-type annotation and PARVA feature plot; G: Distribution of PARVA expression across different cell types in STAD_GSE134520. CD8T: Cytotoxic T lymphocyte; DC: Dendritic cells.

Citation: Lu X, Li J, Wang ML, Wang HZ, Li YX. PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling. World J Gastrointest Oncol 2026; 18(10): 121827
URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121827.htm
DOI: https://dx.doi.org/10.4251/wjgo.121827

Lu X, Li J, Wang ML, Wang HZ, Li YX. PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling. World J Gastrointest Oncol 2026; 18(10): 121827 [DOI: 10.4251/wjgo.121827]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.